Action - MAPP

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

24,98

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

24,98

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...

Allergan, Inc. (NYSE: AGN) (“Allergan”) today announced the expiration of the tender offer (the “Offer”) initiated by its wholly-owned...

Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per...

Allergan, Inc. (NYSE: AGN) (“Allergan”) and MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) (“MAP”) today announced that the Federal Trade...

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut

NEW YORK, Feb. 1, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of MAP Pharmaceuticals Inc. ("MAP" or the "Company") (Nasdaq:MAPP...

Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug

Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug Pharmaceutical Company Achieves Positive In-Vitro Testing...

Allergan Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals

Allergan, Inc. (NYSE: AGN) (“Allergan”) today announced that its wholly-owned subsidiary, Groundhog Acquisition, Inc. (“Purchaser”), has...

Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors...

Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)

Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP) /* Style Definitions */ span.prnews_span { font-size:8pt; fon...

Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of MAP...

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmace...

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceuticals Inc...

Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-fa...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

MAPP - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 24,98

What is the 1 year trading range for share price?

has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
JTAIJet AI Inc	US$ 6,02 (133,33%)	104,48M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	254,39M
WRDWeRide Inc	US$ 31,4877 (83,39%)	21,07M
INLFINLIF Limited	US$ 16,27 (80,58%)	7,68M
MBRXMoleculin Biotech Inc	US$ 2,1201 (66,94%)	136,66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3,08 (-56,31%)	430,77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3,36 (-52,68%)	5,21k
CSAICloudastructure Inc	US$ 19,0001 (-49,58%)	1,03M
NEXNNexxen International Ltd	US$ 10,30 (-49,16%)	164,82k
BSLKBolt Projects Holdings Inc	US$ 0,6626 (-46,13%)	13,4M
CNSPCNS Pharmaceuticals Inc	US$ 0,1415 (31,26%)	480,49M
MGOLMGO Global Inc	US$ 0,7176 (-15,08%)	411,17M
SRMSRM Entertainment Inc	US$ 0,6999 (95,50%)	248,48M
INTCIntel Corporation	US$ 23,60 (-2,20%)	225,04M
NVDANVIDIA Corporation	US$ 138,85 (2,63%)	189,56M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Map Pharmaceuticals, Inc. (MM) (MAPP)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MAPP Dernières nouvelles

Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...

Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per...

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut

Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug

Allergan Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals

Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)

Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)

Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmace...

Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.

MAPP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Map Pharmaceuticals, Inc. (MM) (MAPP) Cours

Map Pharmaceuticals, Inc. (MM) (MAPP)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MAPP Dernières nouvelles

Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc...

Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per...

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut

Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug

Allergan Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals

Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of MAP Pharmaceuticals, Inc. (MAPP)

Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)

Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmace...

Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.

MAPP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS